These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 4906106)

  • 1. [Initial provisional record of a controlled trial of isoniazid-rifomycin-thiocarlide versus isoniazid-streptomycin-thiocarlide in active pulmonary tuberculosis not yet treated].
    Willa C; Favez G
    Acta Tuberc Pneumol Belg; 1969; 60(3):577-82. PubMed ID: 4906106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 3. [Initial provisional record of treatment of relapses of active pulmonary tuberculosis with combined rifomycin, ethambutol and thiocarlide].
    Favez G; Willa C
    Acta Tuberc Pneumol Belg; 1969; 60(3):496-500. PubMed ID: 5392721
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of treatment by a combination of thiocarlide and isoniazid in previously untreated pulmonary tuberculosis].
    Aksüğür H; Gülbaran R; Cakirca R
    Poumon Coeur; 1967; 23(6):729-38. PubMed ID: 6070030
    [No Abstract]   [Full Text] [Related]  

  • 5. Original course of chemotherapy in pulmonary tuberculosis with a double drug regimen: isoniazid-streptomycin versus isoniazid-thiocarlide.
    Favez G; Gonin JD; Gubéran E; De Kalbermatten JP; Vulliémoz P; Willa C
    Antibiot Chemother; 1970; 16():156-9. PubMed ID: 5535611
    [No Abstract]   [Full Text] [Related]  

  • 6. Results and randomized original treatment in cases of pulmonary tuberculosis with isoniazid-streptomycin versus isoniazid-thiocarlide.
    Favez G; Gonin JD; Gubéran E; De Kalbermatten JP; Willa C; Vulliémoz P
    Chest; 1970 Mar; 57(3):234-8. PubMed ID: 5461222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Thiocarlide. Attempt of an evaluation].
    Protivinsky R
    Ther Ggw; 1969 Oct; 108(10):1410-1 passim. PubMed ID: 4908478
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative controlled trial of rimactane in pulmonary tuberculosis.
    Dormer BA
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):188. PubMed ID: 4895449
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experiences with thiocarlide (Isoxyl) in combination therapy of freshly evaluated tuberculosis.
    Nickling HG
    Antibiot Chemother; 1970; 16():136-8. PubMed ID: 5535609
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
    Daddi G
    Wien Med Wochenschr; 1967 Mar; 117(11):266-8. PubMed ID: 5626324
    [No Abstract]   [Full Text] [Related]  

  • 11. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical results obtained by rifomycin treatment of patients with recent tuberculosis].
    Daddi G; Lucchesi M
    Acta Tuberc Pneumol Belg; 1969; 60(3):521-6. PubMed ID: 5371677
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
    Kraan JK; Mulder RJ; van Dijk B
    Acta Tuberc Pneumol Belg; 1969; 60(3):557-62. PubMed ID: 4906104
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current status of chemotherapy of pulmonary tuberculosis and its further prospectives].
    Eule H
    Z Erkr Atmungsorgane Folia Bronchol; 1971; 134(2):313-53. PubMed ID: 4934592
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental chemotherapy of tuberculosis].
    Krebs A
    Z Erkr Atmungsorgane Folia Bronchol; 1969; 130(5):417-48. PubMed ID: 4899157
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
    Meissner G
    Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day].
    Kreis B; Israël L; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1091-108. PubMed ID: 5387445
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative results of medium and increased doses of isoniazid in the triple treatment of overt pulmonary tuberculosis].
    Favez G; Maillard JM; Vouilloz M
    Schweiz Med Wochenschr; 1968 Sep; 98(36):1392-5. PubMed ID: 5693896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.